These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20947847)

  • 1. Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease.
    Rouhl RP; van Oostenbrugge RJ; Theunissen RO; Knottnerus IL; Staals J; Henskens LH; Kroon AA; de Leeuw PW; Lodder J; Tervaert JW; Damoiseaux JG
    Stroke; 2010 Nov; 41(11):2687-9. PubMed ID: 20947847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
    J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between oxidized low-density lipoprotein antibodies and hematological diseases.
    Li H; Li DQ; Li XX; Wang LQ
    Lipids Health Dis; 2016 Nov; 15(1):190. PubMed ID: 27825356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM; Cojocaru M; Burcin C
    Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection.
    Yilmaz A; Jennbacken K; Fogelstrand L
    BMC Infect Dis; 2014 Mar; 14():143. PubMed ID: 24636004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
    Kankaanpää J; Turunen SP; Moilanen V; Hörkkö S; Remes AM
    Neurobiol Dis; 2009 Mar; 33(3):467-72. PubMed ID: 19130885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.
    van Bommel EF; van Tits LJ; van den Berg EA; Prins J; Stalenhoef AF
    Rheumatol Int; 2011 Feb; 31(2):201-8. PubMed ID: 20012624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against phospholipids and oxidized LDL in alcoholic patients.
    Zima T; Fialová L; Mikulíková L; Malbohan IM; Popov P; Nespor K
    Physiol Res; 1998; 47(5):351-5. PubMed ID: 10052604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.
    Slot MC; Theunissen R; van Paassen P; Damoiseaux JG; Tervaert JW;
    Clin Exp Immunol; 2007 Aug; 149(2):257-64. PubMed ID: 17521320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation.
    Fang JC; Kinlay S; Behrendt D; Hikita H; Witztum JL; Selwyn AP; Ganz P
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2044-8. PubMed ID: 12482832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.